177 results on '"Poyet, Cedric"'
Search Results
2. A Novel Machine Learning-based Predictive Model of Clinically Significant Prostate Cancer and Online Risk Calculator
3. Ex Vivo Drug Testing in Patient-derived Papillary Renal Cancer Cells Reveals EGFR and the BCL2 Family as Therapeutic Targets
4. Oncological and functional outcomes after testis-sparing surgery in patients with germ cell tumors: a systematic review of 285 cases
5. Long-Term Oncological Efficacy of Retroperitoneoscopic Radical Nephrectomy of Localized Renal Cell Cancer pT1-3 (≤12 cm)
6. Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort
7. Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy
8. Use of MS-GUIDE for identification of protein biomarkers for risk stratification of patients with prostate cancer
9. Accommodating heterogeneous missing data patterns for prostate cancer risk prediction
10. Gleason grade accuracy of transperineal and transrectal prostate biopsies in MRI-naïve patients
11. Effectiveness of Flexible Ureterorenoscopy Versus Extracorporeal Shock Wave Lithotripsy for Renal Calculi of 5–15 mm: Results of a Randomized Controlled Trial
12. Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent
13. Postoperative Chemotherapy Bladder Instillation After Radical Nephroureterectomy: Results of a European Survey from the Young Academic Urologist Urothelial Cancer Group
14. The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group
15. Characterization of Tumor Blood Vasculature Expression of Human Invasive Bladder Cancer by Laser Capture Microdissection and Transcriptional Profiling
16. Three-Dimensional Texture Analysis with Machine Learning Provides Incremental Predictive Information for Successful Shock Wave Lithotripsy in Patients with Kidney Stones
17. A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts
18. Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?
19. Diagnostic accuracy of preoperative lymph node staging of bladder cancer according to different lymph node locations: A multicenter cohort from the European Association of Urology – Young Academic Urologists
20. Detecting circulating tumor DNA in renal cancer: An open challenge
21. Convergent network effects along the axis of gene expression during prostate cancer progression
22. Basic Hallmarks of Urothelial Cancer Unleashed in Primary Uroepithelium by Interference with the Epigenetic Master Regulator ODC1
23. BioPrev-C -- development and validation of a contemporary prostate cancer risk calculator.
24. Alternative transcription of a shorter, non-anti-angiogenic thrombospondin-2 variant in cancer-associated blood vessels
25. External Evaluation of a Novel Prostate Cancer Risk Calculator (ProstateCheck) Based on Data from the Swiss Arm of the ERSPC
26. Long-Term Oncologic Outcome of an Initial Series of Laparoscopic Radical Prostatectomy for Clinically Localized Prostate Cancer After a Median Follow-up of 10 Years
27. TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer
28. Impact of tumor size on the oncological outcome of high-grade nonmuscle invasive bladder cancer – examining the utility of classifying Ta bladder cancer based on size
29. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade
30. Comparative analysis of mRNA and protein degradation in prostate tissues indicates high stability of proteins
31. Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools
32. Long-term Adverse Effects of Extracorporeal Shock-wave Lithotripsy for Nephrolithiasis and Ureterolithiasis: A Systematic Review
33. Acute Abdominal Pain Accompanied by High Creatinine in a Female Patient With Schizophrenia
34. Absorption of Irrigation Fluid Occurs Frequently during High Power 532 nm Laser Vaporization of the Prostate
35. Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer
36. Effect of Propofol Versus Sevoflurane on Erections during Narcosis in Transurethral Surgery: The PENIS Trial
37. The German version of the Expanded Prostate Cancer Index Composite (EPIC): translation, validation and minimal important difference estimation
38. Conditional analyses of recurrence and progression in patients with TaG1 non–muscle-invasive bladder cancer
39. Creation and internal validation of a biopsy avoidance prediction tool to aid in the choice of diagnostic approach in patients with prostate cancer suspicion
40. SYSTEMIC INFLAMMATORY RESPONSE MARKERS IN PATIENTS WITH METASTATIC GERM CELL TUMORS UNDERGOING CHEMOTHERAPY MIGHT BE OF PROGNOSTIC VALUE: MP81-03
41. DO WE ABLATE MORE TISSUE USING THE 180W XPS GREENLIGHT LASER? RESULTS FROM A PROSPECTIVE 120W HPS VS. 180W XPS GREENLIGHT LASER 3D-VOLUMETRY STUDY: MP42-12
42. COMPARISON OF STONE-FREE RATES BETWEEN EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY (ESWL) AND FLEXIBLE URETERORENOSCOPY (FURS) FOR UNTREATED RENAL CALCULI: MP33-19
43. HOW ACCURATE IS THE PSA TEST? A PREVALENCE STUDY OF DISTURBED PSA VALUES IN A TERTIARY REFERRAL HOSPITAL: MP21-03
44. MP86-07 ASSOCIATION OF METFORMIN USE WITH PROSTATE CANCER INCIDENCE IN A PROSPECTIVE SCREENING TRIAL (ERSPC AARAU)
45. LOSS OF POWER OUTPUT IS FREQUENTLY DETECTABLE DURING LASER VAPORIZATION OF THE PROSTATE USING THE 180-WATT 532 NM LASER IN COMBINATION WITH MOXYTM LASER FIBERS: MP71-19
46. COMPARISON OF THREE DIFFERENT RISK CALCULATOR TO PREDICT PROSTATE CANCER BEFORE BIOPSY - RESULTS FROM A RETROSPECTIVE STUDY IN ZüRICH: MP63-10
47. Single-Cell Proteomics Defines the Cellular Heterogeneity of Localized Prostate Cancer
48. Differential DNA Methylation of THOR and hTAPAS in the Regulation of hTERT and the Diagnosis of Cancer.
49. Proteogenomic heterogeneity of localized human prostate cancer progression
50. ABLATIVE EFFICIENCY OF GREENLIGHT LASER VAPORIZATION AND CONVENTIONAL TRANSURETHRAL RESECTION OF THE PROSTATE 12 MONTHSRESULTS OF A TRANSRECTAL 3D ULTRASOUND VOLUMETRY STUDY: 1984
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.